Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.55 |
| ▸ | WHR1 | P49842 | 1/20 | 0.51 |
| ▸ | CYP1B1 | Q16678 | 3/20 | 0.50 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | ABCG2 | Q9UNQ0 | 4/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.46 |
| ▸ | RELA | Q04206 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | DHFR | P00374 | 1/20 | 0.45 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | PRNP | P04156 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31683846 | 0.89 | MEN1 (0.69) | MEN1KMT2AATMWHR1CYP1B1 | |
| SCHEMBL22603326 | 0.89 | MEN1 (0.69) | MEN1KMT2AATMWHR1CYP1B1 | |
| SCHEMBL19320195 | 0.89 | MEN1 (0.69) | MEN1KMT2AATMWHR1CYP1B1 | |
| SCHEMBL18455539 | 0.89 | KMT2A (0.55) | MEN1KMT2AATMWHR1CYP1B1 | |
| SCHEMBL15003695 | 0.89 | MEN1 (0.69) | MEN1KMT2AATMWHR1CYP1B1 | |
| SCHEMBL23352770 | 0.89 | MEN1 (0.69) | MEN1KMT2AATMWHR1CYP1B1 | |
| SCHEMBL28963937 | 0.89 | MEN1 (0.48) | MEN1KMT2AATMWHR1CYP1B1 | |
| SCHEMBL16211433 | 0.87 | MEN1 (0.71) | MEN1KMT2AATMWHR1CYP1B1 | |
| SCHEMBL9889191 | 0.87 | MEN1 (0.71) | MEN1KMT2AATMWHR1CYP1B1 | |
| SCHEMBL29674917 | 0.87 | MEN1 (0.71) | MEN1KMT2AATMWHR1CYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11581496-B2 | Benzocarbazole-based compound and organic light-emitting device comprising same | LG CHEM, LTD. (KR) | 2023-02-14 | — | — | US | disclosed |
| EP-3960733-A1 | BENZOCARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2022-03-02 | — | — | EP | disclosed |
| EP-3960737-A1 | BENZOCARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2022-03-02 | — | — | EP | disclosed |
| US-20190237680-A1 | BENZOCARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-08-01 | — | — | US | disclosed |
| EP-3514152-A1 | BENZOCARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LG Chem, Ltd. (KR) | 2019-07-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190237680-A1 | BENZOCARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CYP1B1, CYP2C9, CYP3A4 | MEN1 2109/4885KMT2A 1220/4885ATM 4058/4885 |
| US-11581496-B2 | Benzocarbazole-based compound and organic light-emitting device comprising same | CYP1B1, CYP2C9, CYP3A4 | MEN1 2109/4885KMT2A 1220/4885ATM 4058/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.